MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler
The new metered dose inhaler delivers a precise formulation of minor cannabinoid CBN and THC in a consistent, smoke-free format. Designed for nighttime use, the product offers a fast onset experience without combustion or vapour, making it a discreet and convenient option for both consumers and medical patients.
David Pidduck, CEO of MediPharm Labs, commented:
'The launch of our CBN THC Metered Dose Inhaler represents a significant step forward in our strategy to deliver innovative, pharma-grade cannabinoid products globally. As international markets increasingly seek smoke-free, precisely dosed formats, MediPharm is well-positioned to lead with differentiated solutions that reflect both consumer wellness trends and medical needs. This product not only strengthens our Canadian portfolio but also supports our broader vision to scale precision cannabinoid delivery methods across regulated cannabis markets worldwide.'
Key Product Highlights:
The Company plans to expand their inhaler offering with additional CBD and CBG options available in the future. MediPharm Labs continues to lead in pharma-grade cannabinoid innovation, offering a diverse range of product formats tailored to the evolving needs of consumers and patients. Inhaled formats like the metered dose inhaler provide rapid onset, while other MediPharm Labs products, such as tinctures, soft chews, and soft gels offer a slower onset and longer-lasting effects.
About MediPharm Labs
MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products utilizing a Good Manufacturing Practices (GMP) certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies, and purpose-built facilities for the delivery of pure, trusted, and precision-dosed cannabis products for its customers. MediPharm Labs develops, formulates, processes, packages, and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets.
In 2021, MediPharm Labs received a Pharmaceutical Drug Establishment License from Health Canada, becoming the only company in North America to hold a commercial-scale domestic Good Manufacturing Practices License for the extraction of multiple natural cannabinoids. This GMP license was the first step in the Company's current foreign drug manufacturing site registration with the US FDA.
In 2023, MediPharm acquired VIVO Cannabis Inc., which expanded MediPharm's reach to medical patients in Canada via Canna Farms medical e-commerce platform, and in Australia and Germany through Beacon Medical PTY and Beacon Medical GMBH. This acquisition also included Harvest Medical Clinics in Canada, which provides medical cannabis patients with physician consultations for medical cannabis education and prescriptions.
The Company carries out its operations in compliance with all applicable laws in the countries in which it operates.
For further information, please contact:
MediPharm Labs Investor Relations
Telephone: +1 416.913.7425
Email:
investors@medipharmlabs.com
Website:
www.medipharmlabs.com
Cautionary Note Regarding Forward-Looking Information:
This news release contains 'forward-looking information' and 'forward-looking statements' (collectively, 'forward-looking statements') within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events, or performance (often but not always using phrases such as 'expects', or 'does not expect', 'is expected', 'anticipates' or 'does not anticipate', 'plans', 'budget', 'scheduled', 'forecasts', 'estimates', 'believes' or 'intends' or variations of such words and phrases or stating that certain actions, events, or results 'may' or 'could', 'would', 'might' or 'will' be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate to, among other things, MediPharm's access to and unique position in the international medical markets, MediPharm's future growth and ability to scale precision cannabinoid delivery methods across regulated cannabis markets worldwide, MediPharm's timing and ability to distribute its metered dose inhalers in Canada, MediPharm's ability to further expand its international portfolio, future growth of cannabinoid products in international markets, wellness trends and medical needs of consumers, and the success of MediPharm's products in Canada, including MediPharm's ability to expand distribution of its metered dose inhaler products to additional provinces and channels. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political, and social uncertainties; the delay or failure to receive regulatory approvals; and other factors discussed in MediPharm Labs' filings, available on the SEDAR+ website at
www.sedarplus.ca
. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, MediPharm Labs assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/14b8b11d-7c8d-4f3f-85ee-322ef92c232b
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
2 hours ago
- Business Upturn
Financière de Tubize – 2025 half-year financial report
By GlobeNewswire Published on August 2, 2025, 11:00 IST Half-year financial report 2025 Regulated information 2 August 2025 The board of directors of Financière de Tubize has established the 2025 half-year report. This report is available on the website Profit for the first half of 2025: € 95.6 million (€ 92.9 million in 2024, + 2.8%), Dividend received from UCB: € 98.1 million (€ 1.39 per share, an increase of 2.2% compared to the previous year), 2024 Dividend paid to Financière de Tubize's shareholders in 2025 of € 46.3 million (€ 1.04 per share, an increase of 7.22% compared to the previous year), Acquisition, in 2025, of 24,487 UCB shares, for a total amount of € 4.37 million, at an average price of € 178.3. Our stake in UCB has increased from 36.27% on 31 December 2024 to 36,28% on 30 June 2025, Decrease of outstanding bank borrowings from € 41.3 million at 31 December 2024 to € nil at 30 June 2025. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Business Upturn
2 hours ago
- Business Upturn
SHARC Energy Announces Update on Convertible Debenture Financing
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) — SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) ('SHARC Energy' or the 'Company') would like to announce its intention to complete a non-brokered private placement of secured convertible debentures (each, a 'Debenture') with a principal amount of up to $1,500,000 (the 'Offering'). The Debenture is secured against all present and after acquired assets of the Company. The Debentures will bear interest at a rate of 8.0% per annum and mature on the date that is 24 months from the date of issuance (the 'Maturity Date'). The holder will have the option to extend the Maturity Date for a period of 12 months and receive all accrued and unpaid interest in cash or in common shares in the capital of the Company ('Common Shares') at a price of $0.10 per Common Share (the 'Conversion Price'). Additionally, the outstanding principal amount owed under a Debenture may be converted into Common Shares at the Conversion Price at the option of the holder at any time on or prior to the last business day prior to the Maturity Date. The Company may from time to time, in its sole discretion, prepay all or a part of the principal amount and accrued interest without penalty. The Company intends to use the proceeds from the Offering for working capital purposes as the Company continues to fulfil the shipment and delivery of SHARC and PIRANHA WET systems. The Company may pay a finder's fee in connection with the Offering to eligible arm's length finders in accordance with applicable securities laws and the policies of the Canadian Securities Exchange. All securities issued in connection with the Offering will be subject to a statutory hold period of four months and one day following the date of issuance in accordance with applicable Canadian securities laws. The securities of the Company referred to in this news release have not been and will not be registered under the United States Securities Act of 1933 , as amended (the 'U.S. Securities Act'), or any state securities laws. Accordingly, the securities of the Company may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company in any jurisdiction in which such offer, solicitation or sale would be unlawful. The above Offering is being carried out in place of the previously announced offering on June 20, 2025, which is now cancelled. About SHARC Energy SHARC International Systems Inc. is a world leader in energy recovery from the wastewater we send down the drain every day. SHARC Energy's systems recycle thermal energy from wastewater, generating one of the most energy-efficient and economical systems for heating, cooling & hot water production for commercial, residential, and industrial buildings along with thermal energy networks, commonly referred to as 'District Energy'. SHARC Energy is publicly traded in Canada (CSE: SHRC), the United States (OTCQB: INTWF) and Germany (Frankfurt: IWIA) and you can find out more on our SEDAR profile. Learn more about SHARC Energy: Website | Investor Page | LinkedIn | YouTube | PIRANHA | SHARC ON BEHALF OF THE BOARD Fred Andriano Chairman The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release. Forward-Looking Statements Certain statements contained in this news release may constitute forward-looking information. Forward-looking information is often, but not always, identified using words such as 'anticipate', 'plan', 'estimate', 'expect', 'may', 'will', 'intend', 'should', and similar expressions. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. SHARC Energy's actual results could differ materially from those anticipated in this forward-looking information because of regulatory decisions, competitive factors in the industries in which the Company operates, prevailing economic conditions, and other factors, many of which are beyond the control of the Company. SHARC Energy believes that the expectations reflected in the forward-looking information are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward-looking information contained in this news release represents the Company's expectations as of the date hereof and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information whether because of new information, future events or otherwise, except as required by applicable securities legislation. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Business Upturn
2 hours ago
- Business Upturn
AI-Powered Crypto OZAK AI Enters the Spotlight as $1,500,000 Raised in Presale
By GlobeNewswire Published on August 2, 2025, 07:00 IST ROAD TOWN, British Virgin Islands, Aug. 01, 2025 (GLOBE NEWSWIRE) — OZAK AI Raises above $1,500,000 in Presale and it's currently priced at $0.005. Visa's growing interest in stablecoins has shifted the focus toward AI-integrated cryptocurrencies. Ozak AI is one among them and is rapidly developing attention. Its ongoing presale has already sold over 66.2 million tokens and raised over 1.53 million. This traction is an indication of a market turning point where blockchain projects featuring AI capabilities are pressing to be relevant to the masses. With clear goals and token transparency, Ozak AI stands out during a pivotal moment. Market participants are now moving toward platforms that blend automation, decentralization, and predictive financial tools. The crypto market, driven by technological innovation, continues aligning with AI and blockchain synergy. The rise of hybrid platforms such as Ozak AI is the next step in supporting the stablecoin space. These machine-learning models promote faster and data-driven models of approaches to the market. Youtube embed: Next 500X AI Altcoin Ozak AI's Predictive Models and Automated Governance Gain Traction Ozak AI utilizes predictive analytics and automated governance to run its decentralized ecosystem. The company uses reinforcement learning and neural networks to analyze large financial data. Such a system allows extensive market predictions and optimal risk control. Users can enjoy real-time alerts, price pattern recognition, and automation of smart contracts. The AI framework conducts the analysis of proposals, delegates voters, and identifies anomalies. These abilities ensure the transparency and operational effectiveness of its decentralized ecosystem. Its decision-making process and rules use smart contracts in governance structures. There is no central authority, and decision-making is in the hands of the token holders who vote on-chain. The system also helps address threats, such as Sybil attacks, by verifying identities and behaviors with the help of AI. $OZ Token Fuels a Decentralized Financial Infrastructure The $OZ token is used to buy, stake and deploy models. Holders of the token are also entitled to vote on security and ecosystem changes. The token will be distributed in phases, and the present price stands at $0.005. The price will be raised to $0.01 in the next phase. A target of 1 is set, which is in line with the maturity of the networks and deployment of features. Its validation entails the network using a staking mechanism to facilitate its incentives. This method promotes efficiency and speed in the execution of smart contracts via Arbitrum Orbit. It also improves the capacity of the DeFi ecosystem to handle a large amount of data traffic. Moreover, the EigenLayer integration with AVS provides safe certification of AI regulation and monetary exchange. Data storage works via DePIN, eliminating one point of failure. Ozak AI Reinforces AI-Blockchain Integration in DeFi and Trading AI agents optimize market entry and exit strategies in volatile environments. These agents examine macroeconomic indicators and trading volumes and price fluctuations. Consequently, traders obtain better timing as well as more accurate markets. Real-time and automated alerts allow an immediate response to market action. Machine learning models continuously adapt and enhance trading accuracy. This adaptability gives Ozak AI a distinct position in the fast-evolving crypto trading space. With stablecoin backing increasing, AI-enhanced platforms, such as Visa, now fill gaps left by traditional tools. Ozak AI combines security, automation, and financial prediction into one system. For more information about Ozak AI, visit the links below. Website: Twitter/X: Telegram: Media Contact: Andres Brinc [email protected] Disclaimer: This content is provided byOzak AI. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. We do not guarantee any claims, statements, or promises made in this article. This content is for informational purposes only and should not be considered financial, investment, or trading in crypto and mining-related opportunities involves significant risks, including the potential loss of capital. It is possible to lose all your capital. These products may not be suitable for everyone, and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. However, due to the inherently speculative nature of the blockchain sector—including cryptocurrency, NFTs, and mining—complete accuracy cannot always be the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page. Legal Disclaimer: This media platform provides the content of this article on an 'as-is' basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above. A photo accompanying this announcement is available at Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
